Tech Company Financing Transactions
Seahorse Bioscience Funding Round
Seahorse Bioscience, operating out of Santa Clara, secured $5 million from Commonwealth Capital Ventures, HealthCare Ventures and HLM Venture Partners.
Transaction Overview
Company Name
Announced On
2/23/2010
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series D
Investors
Proceeds Purpose
Seahorse will use the money to beef up international sales, marketing, and manufacturing of its XF series of instruments, which measure energy in cells are used as a tool for cancer research.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5301 Stevens Creek Blvd.
Santa Clara, CA 95051
USA
Santa Clara, CA 95051
USA
Phone
Website
Email Address
Overview
We design and manufacture consumable sensors and custom injection molded Labware in our Seahorse Labware facility in Massachusetts.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mike McMullen
Chief Financial Officer
Didier Hirsch
Chief Technical Officer
Darlene Solomon
President
Jacob Thaysen
VP - Bus. Development
Shiela Robertson
VP - General Counsel
Michael Tang
VP - Human Resources
Dominique Grau
VP - Regulatory Affairs
Nancy Lelicoff
Browse more venture capital transactions:
Prev: 2/22/2010: Pulmonx venture capital transaction
Next: 2/23/2010: mCaddie venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs